Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2

Biochemical Pharmacology

Volumn 58, Issue 3, 1999, Pages 431-438

  Kristina Walle, U ^a   Galijatovic, Alema ^a   Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bioflavonoids; Caco 2 cells; Chrysin; cMOAT; Efflux; Flavonoids; Glucuronidation; Intestinal absorption; MRP2; Sulfation

Indexed keywords

CHRYSIN; CHRYSIN GLUCURONIDE; CHRYSIN SULFATE; DRUG METABOLITE; ESTRONE SULFATE; FLAVONOID; MANNITOL; MULTIDRUG RESISTANCE PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VERLUKAST;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG CONJUGATION; DRUG GLUCURONIDATION; DRUG HYDROLYSIS; DRUG SULFATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MEMBRANE PERMEABILITY; MODEL; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTI-HIV AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; FLAVONOIDS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; TIME FACTORS;

EID: 0033051339     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00133-1     Document Type: Article

References (44)

1. Hertog MGL, Hollman PCH and Katan MB, Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40: 2379-2383, 1992.
2. Hertog MGL, Hollman PCH and van de Putte B, Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J Agric Food Chem 41: 1242-1246, 1993.
3. Knekt P, Järvinen R, Reunanen A and Maatela J, Flavonoid intake and coronary mortality in Finland: A cohort study. Br Med J 312: 478-481, 1996.
4. Keli SO, Hertog MGL, Feskens EJM and Kromhout D, Dietary flavonoids, antioxidant vitamins, and incidence of stroke: The Zutphen study. Arch Intern Med 156: 637-642, 1996.
5. Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M and Look KY, Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res 16: 3271-3282, 1996.
6. 1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19: 74-82, 1997.
7. Siess M-H, Le Bon A-M, Canivenc-Lavier M-C, Amiot M-J, Sabatier S, Aubert SY and Suschetet M, Flavonoids of honey and propolis: Characterization and effects on hepatic drug-metabolizing enzymes and benzo[a]pyrene-DNA binding in rats. J Agric Food Chem 44: 2297-2301, 1996.
8. Critchfield JW, Butera ST and Folks TM, Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retroviruses 12: 39-46, 1996.
9. Critchfield JW, Coligan JE, Folks TM and Butera ST, Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proc Natl Acad Sci USA 94: 6110-6115, 1997.
10. Tsyrlov IB, Mikhailenko VM and Gelboin HV, Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochim Biophys Acta 1205: 325-335, 1994.
11. Walle T, Eaton EA and Walle UK, Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochem Pharmacol 50: 731-734, 1995.
12. Nielsen SE, Breinholt V, Justesen U, Cornett C and Dragsted LO, In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28: 389-401, 1998.
13. Artursson P, Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79: 476-482, 1990.
14. Meunier V, Bourrié M, Berger Y and Fabre G, The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 11: 187-194, 1995.
15. Walgren RA, Walle UK and Walle T, Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol 55: 1721-1727, 1998.
16. Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T and Keppler D, cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271: 15091-15098, 1996.
17. Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenbeiss J, Burchell B and Keppler D, ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 327: 305-310, 1997.
18. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ and Zaman GJR, Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 54: 4557-4563, 1994.
19. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJT, Juijn JA, Baas F and Borst P, Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57: 3537-3547, 1997.
20. Hipfner DR, Gauldie SD, Deeley RG and Cole SPC, Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 54: 5788-5792, 1994.
21. Hipfner DR, Almquist KC, Stride BD, Deeley RG and Cole SPC, Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res 56: 3307-3314, 1996.
22. Walle UK and Walle T, Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos 26: 343-346, 1998.
23. Shwed JA, Walle UK and Walle T, Hep G2 cell line as a human model for sulphate conjugation of drugs. Xenobiotica 22: 973-982, 1992.
24. Miller DW, Fontain M, Kolar C and Lawson T, The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett 107: 301-306, 1996.
25. Leier I, Jedlitschky G, Buchholz U, Cole SPC, Deeley RG and Keppler D, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27807-27810, 1994.
26. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G and Keppler D, Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56: 988-994, 1996.
27. Keppler D and König J, Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/ cMOAT) gene in liver. FASEB J 11: 509-516, 1997.
28. Salgueiro JB, Ardenghi P, Dias M, Ferreira MBC, Izquierdo I and Medina JH, Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav 58: 887-891, 1997.
29. Walle T, Fagan TC, Conradi EC, Walle UK and Gaffney TE, Presystemic and systemic glucuronidation of propranolol. Clin Pharmacol Ther 26: 167-172, 1979.
30. Kauffman FC, Whittaker M, Anundi I and Thurman RG, Futile cycling of a sulfate conjugate by isolated hepatocytes. Mol Pharmacol 39: 414-420, 1991.
31. Almquist KC, Loe DW, Hipfer DR, Mackie JE, Cole SPC and Deeley RG, Characterization of the Mr 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 55: 102-110, 1995.
32. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
33. Towbin H, Staehelin T and Gordon J, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
34. Schaub TP, Kartenbeck J, König J, Vogel O, Witzgall R, Kriz W and Keppler D, Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8: 1213-1221, 1997.
35. Artursson P and Karlsson J, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175: 880-885, 1991.
36. Prueksaritanont T, Gorham LM, Hochman JH, Tran LO and Vyas KP, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab Dispos 24: 634-642, 1996.
37. Chikhale PJ and Borchardt RT, Metabolism of L-α-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers: Comparison with metabolism in vivo. Drug Metab Dispos 22: 592-600, 1994.
38. Hunter J, Jepson MA, Tsuruo T, Simmons NL and Hirst BH, Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem 268: 14991-14997, 1993.
39. Augustijns PF, Bradshaw TP, Can L-SL, Hendren RW and Thakker DR, Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem Biophys Res Commun 197: 360-365, 1993.
40. Cavet ME, West M and Simmons NL, Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 118: 1389-1396, 1996.
41. Wollenberg P and Rummel W, Vectorial release of sulfoconjugates in the vascularly perfused mouse small intestine. Biochem Pharmacol 33: 205-208, 1984.
42. Paulusma CC, Bosma PJ, Zaman GJR, Bakker CTM, Otter M, Scheffer GL, Scheper RJ, Borst P and Oude Elferink RPJ, Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128, 1996.
43. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y, Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 272: G16-G22, 1997.
44. Makhey VD, Guo A, Norris DA, Hu P, Van J and Sinko PJ, Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15: 1160-1167, 1998.